檢索結果 - Erin Jeter
- Showing 1 - 3 results of 3
-
1
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation 由 Philippe Armand, Yi‐Bin Chen, Robert Redd, Robin Joyce, Jad Bsat, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Parastoo B. Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreofe O. Odejide, Arnold S. Freedman, Austin I. Kim, Jennifer L. Crombie, Caron A. Jacobson, Eric D. Jacobsen, Jeffrey L. Wong, Sanjay S. Patel, Jerome Ritz, Scott J. Rodig, Margaret A. Shipp, Alex F. Herrera
出版 2019Artigo -
2
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation 由 Matthew J. Frigault, Philippe Armand, Robert Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Alex F. Herrera, Parastoo B. Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreife O. Odejide, Arnold S. Freedman, Austin I. Kim, Jennifer L. Crombie, Caron A. Jacobson, Eric D. Jacobsen, Jeffrey L. Wong, Jad Bsat, Sanjay S. Patel, Jerome Ritz, Scott J. Rodig, Margaret A. Shipp, Yi‐Bin Chen, Robin Joyce
出版 2020Artigo -
3
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma 由 Gabriel K. Griffin, Jason L. Weirather, Margaretha G.M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen, Daniel Gusenleitner, Erin Jeter, Christine J. Pak, Evisa Gjini, Bjoern Chapuy, Michael H. Rosenthal, Jie Xu, Benjamin J. Chen, Aliyah R. Sohani, Scott B. Lovitch, Jeremy S. Abramson, Jeffrey J. Ishizuka, Austin I. Kim, Caron A. Jacobson, Ann S. LaCasce, Christopher D.�M. Fletcher, Donna Neuberg, Gordon J. Freeman, F. Stephen Hodi, Kyle Wright, Azra H. Ligon, Eric D. Jacobsen, Philippe Armand, Margaret A. Shipp, Scott J. Rodig
出版 2020Artigo
相關主題
Adverse effect
Antibody
Autologous stem-cell transplantation
Cancer
Clinical endpoint
Clinical trial
Diffuse large B-cell lymphoma
Immunology
Immunotherapy
Internal medicine
Lymphoma
Medicine
Oncology
Pembrolizumab
Surgery
Transplantation
B cell
Biology
Cancer research
Chemotherapy
Histiocyte
Ibritumomab tiuxetan
Immune system
Monoclonal antibody
Radioimmunotherapy
Salvage therapy
T cell
Tumor microenvironment